Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

107.57
-0.4900-0.45%
Volume:222.94K
Turnover:23.95M
Market Cap:1.03B
PE:87.16
High:108.01
Open:107.78
Low:106.86
Close:108.06
52wk High:118.00
52wk Low:90.60
Shares:9.54M
Float Shares:9.54M
Volume Ratio:0.69
T/O Rate:2.34%
Dividend:2.14
Dividend Rate:1.99%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):138.54

Loading ...

Analysts’ Top Healthcare Picks: AbbVie (ABBV), Quantum-Si (QSI)

TIPRANKS
·
Sep 29

Novo Nordisk Says Ozempic Shows Lower Risk of Cardiovascular Events Compared to Eli Lilly's Mounjaro

Reuters
·
Sep 29

Novo Nordisk announces retrospective RWE on Ozempic in type 2 diabets

TIPRANKS
·
Sep 29

Eli Lilly announces positive results from study of Foundayo 17.2 mg

TIPRANKS
·
Sep 29

Novo Nordisk Strikes Second Licensing Deal Since Frosty Capital-Markets Day

Dow Jones
·
Sep 29

Scotiabank Adjusts PT on Merck & Co. to $180 From $155, Keeps Sector Outperform Rating

MT Newswires Live
·
Sep 29

Citi: Sino Biopharmaceutical and STADA Form Biosimilar Strategic Partnership, "Buy" Rating Maintained

Stock News
·
Sep 29

Cyprumed : Eligible to Receive up to $493.00m in Milestones from Merck & Co Collaboration

THOMSON REUTERS
·
Sep 29

Eli Lilly's Foundayo 17.2 Mg was Associated with 1.5% Greater Weight Loss at 52 Weeks

Reuters
·
Sep 29

Lilly Says Foundayo 17.2 Mg Outperforms Oral Semaglutide 25 Mg on Weight Loss, A1C in Indirect Comparison Study

Reuters
·
Sep 29

Eli Lilly - Foundayo 17.2 Mg Shows 1.5% Greater Weight Loss and 0.3% Greater A1c Reduction at 52 Weeks

THOMSON REUTERS
·
Sep 29

Hengrui Pharma and Novo Nordisk Sign Licensing Agreement for HRS-1596 Project

Stock News
·
Sep 29

Merck & Co Inc : Scotiabank Raises Target Price to $180 from $155

THOMSON REUTERS
·
Sep 29

Sino Biopharmaceutical Jumps Nearly 4% as Subsidiary Strikes Strategic Biosimilar Deal with STADA, Securing Up to EUR53 Million in Upfront Payment

Stock News
·
Sep 29

Option traders moderately bearish in Novo Nordisk with shares down 0.22%

TIPRANKS
·
Sep 29

Sector Update: Healthcare

MT Newswires Live
·
Sep 29

Market Chatter: Eli Lilly CEO Plans Larger Deals to Target New Disease Areas

MT Newswires Live
·
Sep 29

Lilly CEO Eyes Bigger Deals in Hunt for Pharma's 'white Spaces' - Bloomberg News

Reuters
·
Sep 29

Eli Lilly CEO tells Bloomberg sees more deals in untapped areas

TIPRANKS
·
Sep 29

Novartis AG Rises Monday, Outperforms Market

Dow Jones
·
Sep 29